Results 131 to 140 of about 21,523 (174)

Patient perspectives on post-operative direct oral anticoagulant for venous thromboembolism prevention in patients with gynecologic cancers undergoing laparotomy. [PDF]

Gynecol Oncol Rep
Black KA, Mateshaytis J, Sevick L, Rogers J, Bisch SP, Flasha P, Pin S.   +6 more
europepmc   +1 more source

Venous Thromboembolism Management and Anticoagulation Opportunities in Cancer Patients. [PDF]

Eur Cardiol
Szmit S, Krzakowski M, Kowalski DM, Zaborowska-Szmit M.   +3 more
europepmc   +1 more source

MRI Findings of Intracranial Hemorrhages in ARCADIA-MRI: An Ancillary Study to the ARCADIA Trial. [PDF]

AJNR Am J Neuroradiol
Chen H, Lansberg M, Zhu G, Cassarly C, Paula Q, Kemp S, Howard G, Smith EE, Tirschwell D, Sheth KN, Kamel H, Longstreth WT, Elkind MSV, Broderick J, Lazar RM, Wintermark M.   +15 more
europepmc   +1 more source

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation. [PDF]

J Am Heart Assoc
Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S.   +10 more
europepmc   +1 more source

Analysis of the clinical characteristics of direct oral anticoagulants-associated atraumatic splenic rupture. [PDF]

Front Pharmacol
Shi C, Wang X, Zhang S, Guo R, Wu T.
europepmc   +1 more source

Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers. [PDF]

Res Pract Thromb Haemost
Kumar R, Drake E, Stanek J, Yeager N, Vrooman LM, Silverman LB, Rodriguez V.   +6 more
europepmc   +1 more source

Economic evaluation of direct oral anticoagulants (DOACs) for venous thromboembolism with different etiologies: a systematic review. [PDF]

Health Econ Rev
Karimi F, Rajaie S, Azari S, Abbaszadeh MS, Karimi Z.   +4 more
europepmc   +1 more source

Véralvadásra ható szerek II [PDF]

, 2016
Béni, Szabolcs, Rácz, Ákos
core  

A multicenter prospective real-world cohort study of direct oral anticoagulant use for venous thromboembolism prophylaxis in nephrotic syndrome. [PDF]

BMC Nephrol
Meena P, Kumar N, Panda SK, Kandari S, Prasad GS, Bhargava V, Khandelia V, Malviya P, Rout NK, Das P, Garg A, Mylliemngap B, Kumari P.   +12 more
europepmc   +1 more source

Reduced Versus Full-Dose Direct Oral Anticoagulants for Long-Term Management of Venous Thromboembolism: A Systematic Review. [PDF]

J Clin Med
Al Arifi M, Alshahrani WA, Alshehri AM, Al Yami MS.   +3 more
europepmc   +1 more source